# AMC Health

> AMC Health combines connected home medical devices, clinical analytics and clinician-led care for people with chronic conditions. It sells virtual care programs to health plans, providers and government organizations, with an outcomes-based Accountable Primary Care offering announced in October 2026.

- **Founded:** 2002
- **Headquarters:** New York, United States
- **Founders:** Nesim Bildirici (Founder and CEO)
- **Products:** CareConsole, Remote Patient Monitoring, Virtual Clinical Network, Accountable Primary Care, CGM data integration
- **Notable:** CareConsole received an FDA substantial-equivalence decision under K233446 on September 27, 2024., Geisinger’s published 2014 observational analysis estimated 11.3% lower cost of care and a 3.3 return on investment for its telemonitoring program., HITRUST certification announced in February 2024; current company materials state HITRUST CSF r2 certification.

## Products & services

- **CareConsole** — FDA-cleared Class II software that collects and stores home biometric data and supports clinician-scheduled monitoring. FDA decision K233446 dated September 27, 2024.
- **Remote Patient Monitoring** — Personalized connected-device kits, onboarding, logistics and data transmission using an app, cellular tablet, cellular modem or telephonic interactive voice response.
- **Virtual Clinical Network** — Multidisciplinary clinical care and case management, integrated with home data and analytics.
- **Accountable Primary Care** — Primary care and between-visit management for high-risk Medicare Advantage members, with performance compensation tied to validated savings under the October 2026 model.
- **CGM data integration** — Integration of Dexcom G5, G6 and G7 continuous glucose monitoring data announced January 4, 2024.
- **Decentralized Clinical Trial services** — Remote monitoring operations for sponsors and contract research organizations; leadership and advisory expansion announced in April and May 2026.

## Achievements

- CareConsole received an FDA substantial-equivalence decision under K233446 on September 27, 2024.
- Geisinger’s published 2014 observational analysis estimated 11.3% lower cost of care and a 3.3 return on investment for its telemonitoring program.
- HITRUST certification announced in February 2024; current company materials state HITRUST CSF r2 certification.

## Latest updates

- **2026-10** — Announced performance-based Accountable Primary Care model and a $4.2 million annual savings guarantee for a typical 1,000-member high-risk Medicare Advantage cohort, subject to agreed controls and claims validation.
- **2026-05** — Appointed Sol Babani and Symbiosis Advisors as strategic adviser to its decentralized clinical trial service line.
- **2026-04** — Appointed Keith Tode executive vice president for decentralized clinical trials.
- **2026-01** — Announced patient-specific, longitudinal alerting methodology using more than 15 million readings; projected 45% fewer alerts, with controlled evaluation planned.

## Links

- Website: https://www.amchealth.com/
- LinkedIn: https://www.linkedin.com/company/amc-health/
- Twitter/X: https://twitter.com/amchealth
- Instagram: https://www.instagram.com/amc_health/
- Facebook: https://www.facebook.com/AdvancedMonitoredCaregiving/

---

Profile page: https://yespress.io/amc-health
Published by YesPress — https://yespress.io
Last updated: 2026-10-24